$LLY next $1T company?
🚀 Eli Lilly’s weight-loss drug tirzepatide has taken the world by storm! After its success, CEO Dave Ricks is accelerating the development of even more powerful obesity treatments. Stay tuned for more breakthroughs! 🌟
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。